2519
Recent studies have shown that under experimental conditions ferrous sulfate may reduce the gastrointestinal absorption of orally administered levothyroxine sodium in patients with primary hypothyroidism.
 patients with primary hypothyroidism: Subject; primary hypothyroidism: Subject.Disorder; reduce the gastrointestinal absorption of orally administered levothyroxine sodium: Effect; ferrous sulfate: Treatment; orally administered levothyroxine sodium: Treatment; ferrous sulfate: Treatment.Drug; levothyroxine sodium: Treatment.Drug; orally: Treatment.Route; ferrous sulfate: Combination.Drug; levothyroxine sodium: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 patients with primary hypothyroidism: Subject; primary hypothyroidism: Subject.Disorder; reduce the gastrointestinal absorption of orally administered levothyroxine sodium: Effect; ferrous sulfate: Treatment; orally administered levothyroxine sodium: Treatment; ferrous sulfate: Treatment.Drug; levothyroxine sodium: Treatment.Drug; orally: Treatment.Route; ferrous sulfate: Combination.Drug; levothyroxine sodium: Combination.Drug